Investment in African pharma sector highlights growing trend
Actis, an investment firm specializing in growth markets, recently made a significant investment in Medis Group, a branded generic pharmaceuticals business based in North Africa. Medis was the first pharmaceutical company to launch sterile products in North Africa, and is responsible for building one of the first oncology laboratories on the continent. The company plans…